An initial evaluation in 2005 of substances known as antioxydants, vitamin A, vitamin C, vitamin E, carotene, selenium failed to establish that they had a preventive effect against various diseases.
A new review of 68 trials testing the preventive effects of antioxydants against various diseases shows that the death rate was not influenced by antioxydants. A review of 47 high- quality trials involving more than 180,000 participants shows a higher death rate in the groups treated with vitamins A and E and beta-carotene. Another analysis based on more than 150,000 people showed no difference between antioxydants and placebo in preventing macular degeneration (disease of the eye). A trial on prevention of type 2 diabetes compared selenium treatment with a placebo in more than 1200 people. After monitoring for an average of 7.7 years, the incidence of diabetes was 12.6 cases per 1000 people a year in patients receiving selenium, compared with 8.4 cases in those taking the placebo.
Overall, numerous trials evaluating antioxydants show that their preventive effect is hypothetical; there is even evidence of a higher death rate and higher morbidity with some antioxydants.
©Prescrire June 2008
Reference: "Antioxydants : pas en prévention (suite)" Rev Prescrire 2008 ; 28 (296): 455-456.
- Click here for more articles in Prescrire's "Spotlight"